Form 4: Palantir Director Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
A director at Palantir Technologies Inc. sold 800 shares of Class A Common Stock for $139.61 per share on July 9, 2025, as part of a pre-established Rule 10b5-1 trading plan.
Summary
- Palantir Technologies Inc. (PLTR) director Lauren Elaina Friedman sold 800 shares of Class A Common Stock.
- The transaction occurred on July 9, 2025, with shares sold at a price of $139.61 each.
- The sale was executed under a Rule 10b5-1 trading plan, which was established on September 12, 2024.
- Following the transaction, Lauren Elaina Friedman directly beneficially owns 62,887 shares of Class A Common Stock.
- Indirect beneficial ownership includes 80,794 shares held by a spouse and 7,335 shares held by a child's 2025 gift trust, for which the reporting person serves as trustee.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document reports a routine insider stock sale conducted under a pre-arranged Rule 10b5-1 trading plan, which is a common practice for managing personal liquidity and is not typically indicative of a change in company outlook or performance.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled transaction rather than a reaction to new, non-public information.
Negatives
- A director sold 800 shares of Class A Common Stock, which represents a reduction in direct beneficial ownership.
Risks
- No specific new risks were disclosed in this filing beyond the general implications of insider selling, which is mitigated by the pre-arranged trading plan.
Future Outlook
No forward-looking statements or guidance were provided in this Form 4 filing.
Management Comments
- The filing was signed by Justin V. Laubach under power of attorney for Lauren Elaina Friedman.
Industry Context
This Form 4 filing is specific to an individual insider transaction at Palantir Technologies Inc. and does not provide information relevant to broader industry trends or competitor analysis.
Comparison to Industry Standards
- Not applicable, as this document reports a specific insider transaction rather than company performance or operational results that can be benchmarked against industry standards.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- No legal proceedings or regulatory matters were disclosed in this document.
Related Party Transactions
- The reporting person serves as trustee for a child's 2025 gift trust, which holds 7,335 shares of Class A Common Stock indirectly beneficially owned by the reporting person.
Stakeholder Impact
- Shareholders: The sale of 800 shares by a director is a minor transaction and is unlikely to have a significant direct impact on the overall share price or shareholder value, especially given it was pre-planned.
- Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this insider transaction report.
Next Steps
- No specific future actions, events, or milestones for the company were mentioned in this filing.
Key Dates
| Date | Description |
|---|---|
| September 12, 2024 | Date Rule 10b5-1 trading plan was entered into. |
| April 25, 2025 | Date of the Issuer's Proxy Statement filing, referenced for overall stock and equity holdings. |
| July 9, 2025 | Date of the reported transaction (sale of Class A Common Stock). |
| July 11, 2025 | Date the Form 4 was signed and filed. |
Keywords
Palantir, PLTR, SEC Form 4, Insider Trading, Stock Sale, Director, Rule 10b5-1 Plan, Equity Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.